Join
Live feed
·
PRReleasevia Quantisnow
YS Biopharma Co. Ltd. logo

YS Biopharma to Hold Extraordinary General Meeting on May 21, 2024 and Announces the Appointment of Interim Chief Executive Officer

ByQuantisnow·Wall Street's wire, on your screen.
YS· YS Biopharma Co. Ltd.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track YS (YS Biopharma Co. Ltd.) and more on Quantisnow.